Updates

September 24, 2020September 22, 2020
Parenting a Child With Juvenile Arthritis Requires Balance

When you say “juvenile arthritis,” many people imagine it’s the same disease that affects older people. (Hint: It’s not.) But despite having an “old ... Read more
September 24, 2020September 24, 2020
Lower Doses of Ilaris Can Maintain Clinical Remission in Systemic-onset JIA, Trial Shows

Treatment with Ilaris (canakinumab) at doses lower than the one recommended might be enough to maintain clinical remission in people with systemic juvenile idiopathic arthritis ... Read more
September 17, 2020September 15, 2020
Overcoming Loneliness Caused by Juvenile Arthritis

Juvenile arthritis can be such an isolating disease. Flares can cause you to miss out on activities and events. Doctors’ appointments may mean missing ... Read more
September 17, 2020September 17, 2020
Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

Health Canada has expanded the approved use of Brenzys, a biosimilar of Enbrel (etanercept), to include the treatment of juvenile idiopathic arthritis (JIA) and other ... Read more
September 11, 2020September 11, 2020
Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

Early treatment with biologics is increasingly being given to children newly diagnosed with systemic juvenile idiopathic arthritis (sJIA) in the U.S., but their use varies ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

September 22, 2017September 22, 2017

Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis

News

A recent study showed that children with juvenile idiopathic arthritis (JIA) now have similar growth and weight gain as children in the general population. Nonetheless, about 1 in 10 JIA children with systemic arthritis, uncontrolled disease, or prolonged use of ... Read more

Updates

Parenting a Child With Juvenile Arthritis Requires Balance

Lower Doses of Ilaris Can Maintain Clinical Remission in Systemic-onset JIA, Trial Shows

Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

Subscribe to our mailing list

How to Stay Positive When Others Share Negative JA Experiences

Injuries Can Be a Big Deal With Juvenile Arthritis

Nepexto, Biosimilar of Enbrel, Now Available in Germany

Getting a Diagnosis Sometimes Brings Considerable Relief

Humira Shows Long-term Efficacy and Safety in Polyarticular JIA, Phase 3 Trial Reports

5 Overlapping Symptoms of JA and Depression

JIA Type and Medication Use Affect Longevity of Joint Implants, Study Reports

4 Ways to Ease the Pain of Biologic Injections

Sometimes Kids With Juvenile Arthritis Need Encouragement

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

For a Child Newly Diagnosed With JA, There’s Hope for the Future

Fundraisers and Fun Mark July, Juvenile Arthritis Awareness Month

When Juvenile Arthritis Becomes the Butt of the Joke

Hulio, Biosimilar of Humira, Wins FDA Approval for JIA, But Not Available Until 2023

‘Inside Out’ Helps Kids With JA Talk About Their Feelings

Is Remote Learning the Best Option for Kids with JA?

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

During JA Flares, Just Keep Moving Forward

Enbrel Biosimilar Nepexto Approved in Europe for JIA, Other Inflammatory Disorders

When Juvenile Arthritis Predicts the Weather

Teens in Netherlands Can Disregard Disease in Planning for Future, Survey Finds

Feeling Overwhelmed by Pediatric Rheumatology Appointments?

Nearly One-fifth of Infections Opportunistic in JIA Children on Immunosuppressants, Study Reports

Do Kids with Juvenile Arthritis Need Gluten-free Diets?

Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis

Pin It on Pinterest

Parenting a Child With Juvenile Arthritis Requires Balance

Lower Doses of Ilaris Can Maintain Clinical Remission in Systemic-onset JIA, Trial Shows

Overcoming Loneliness Caused by Juvenile Arthritis

Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

Subscribe to our mailing list

How to Stay Positive When Others Share Negative JA Experiences

Injuries Can Be a Big Deal With Juvenile Arthritis

Nepexto, Biosimilar of Enbrel, Now Available in Germany

Getting a Diagnosis Sometimes Brings Considerable Relief

Humira Shows Long-term Efficacy and Safety in Polyarticular JIA, Phase 3 Trial Reports

5 Overlapping Symptoms of JA and Depression

JIA Type and Medication Use Affect Longevity of Joint Implants, Study Reports

4 Ways to Ease the Pain of Biologic Injections

Sometimes Kids With Juvenile Arthritis Need Encouragement

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

For a Child Newly Diagnosed With JA, There’s Hope for the Future

Fundraisers and Fun Mark July, Juvenile Arthritis Awareness Month

When Juvenile Arthritis Becomes the Butt of the Joke

Hulio, Biosimilar of Humira, Wins FDA Approval for JIA, But Not Available Until 2023

‘Inside Out’ Helps Kids With JA Talk About Their Feelings

Is Remote Learning the Best Option for Kids with JA?

How to Thoughtfully Raise Awareness About Juvenile Arthritis

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

During JA Flares, Just Keep Moving Forward

Enbrel Biosimilar Nepexto Approved in Europe for JIA, Other Inflammatory Disorders

When Juvenile Arthritis Predicts the Weather

Teens in Netherlands Can Disregard Disease in Planning for Future, Survey Finds

Feeling Overwhelmed by Pediatric Rheumatology Appointments?

Nearly One-fifth of Infections Opportunistic in JIA Children on Immunosuppressants, Study Reports

Do Kids with Juvenile Arthritis Need Gluten-free Diets?

Pin It on Pinterest